JNBY (03306) announced its interim results, with net profit attributable to shareholders increasing by 4.71% year-on-year to 599.5 million yuan.

26/02/2025

GMT Eight

JNBY (03306) announced its interim results for the six months ending December 31, 2024. The group's revenue reached 3.156 billion yuan, a 5% increase compared to the same period last year. The profit attributable to the company's shareholders was 599.5 million yuan, a 4.71% increase. The basic earnings per share were 1.17 yuan, and the company plans to distribute an interim dividend of 0.45 Hong Kong dollars per share. The announcement stated that the growth in revenue was mainly due to the increase in sales through online channels and the expansion of offline store locations.

JNBY(03306) will distribute a mid-year dividend of HK$0.45 per share on April 17th.

Shanghai Fosun Pharmaceutical (02196): The drug registration application for the injection of bromohexine hydrochloride has been accepted.

Contact: contact@gmteight.com

JNBY (03306) announced its interim results, with net profit attributable to shareholders increasing by 4.71% year-on-year to 599.5 million yuan.

RECOMMEND

Macquarie: Downgrade ASMPT (00522) to "Neutral" rating, lower target price to 68 Hong Kong dollars.

HK Stock Market Move | ZJLD (06979) rose more than 6% during the trading day. Liquor companies are intensively controlling inventory during the off-peak season, with Zhenjiu recently implementing measures to control quantity and maintain prices.

HK Stock Market Move | Yongda Auto (03669) rose nearly 11%, the chairman proposed a layout for incubation Siasun Robot & Automation and Shenzhen New Industries Biomedical Engineering companies to accelerate the expansion of the new energy vehicle network layout.